SANUWAVE Health appoints Andrew Walko as President with $230K salary and 22.5M share option grant

SANUWAVE Health, Inc.

Andrew Walko appointed President effective July 31, 2023; previously President at Biomerics.
Base salary of $230,000 with annual bonus potential of 25% of base salary.
Option grant for 22.5 million shares vesting in three equal tranches over 36 months.
Walko brings 17 years of medical device contract manufacturing and supply chain experience.
CEO Morgan Frank states Walko will help expand manufacturing capabilities and drive growth.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Andrew Walko

President

SNWV · SANUWAVE Health, Inc.

Effective: 2023-07-31
Filed: July 31, 2023, 7:59 PM ET

Effective July 31, 2023, the Board of Directors of SANUWAVE Health, Inc. (the “Company”) appointed Andrew Walko as the Company’s President.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Andrew Walko was appointed as President at SANUWAVE Health, Inc..

Action: appointed
Role: President

Exact text from the filing

Effective July 31, 2023, the Board of Directors of SANUWAVE Health, Inc. (the “Company”) appointed Andrew Walko as the Company’s President.

View on SEC.gov

SANUWAVE Health, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-037100

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.